Allianz Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $303M | Buy |
1,393,938
+134,715
| +11% | +$29.9M | 0.32% | 61 |
|
|
2025
Q4 | $288M | Sell |
1,259,223
-350,119
| -22% | -$79.8M | 0.29% | 60 |
|
|
2025
Q3 | $373M | Buy |
1,609,342
+73,722
| +5% | +$15M | 0.42% | 35 |
|
|
2025
Q2 | $285M | Sell |
1,535,620
-63,525
| -4% | -$11.8M | 0.34% | 52 |
|
|
2025
Q1 | $335M | Sell |
1,599,145
-395,339
| -20% | -$76.9M | 0.44% | 36 |
|
|
2024
Q4 | $354M | Sell |
1,994,484
-439,908
| -18% | -$80.9M | 0.47% | 33 |
|
|
2024
Q3 | $481M | Buy |
2,434,392
+369,157
| +18% | +$68.9M | 0.67% | 23 |
|
|
2024
Q2 | $354M | Buy |
2,065,235
+321,262
| +18% | +$53.2M | 0.52% | 32 |
|
|
2024
Q1 | $318M | Buy |
1,743,973
+296,116
| +20% | +$51M | 0.49% | 42 |
|
|
2023
Q4 | $224M | Buy |
1,447,857
+235,409
| +19% | +$34.3M | 0.37% | 50 |
|
|
2023
Q3 | $181M | Sell |
1,212,448
-93,126
| -7% | -$13.7M | 0.3% | 57 |
|
|
2023
Q2 | $176M | Sell |
1,305,574
-223,334
| -15% | -$32.8M | 0.31% | 54 |
|
|
2023
Q1 | $244M | Buy |
1,528,908
+55,714
| +4% | +$8.52M | 0.43% | 41 |
|
|
2022
Q4 | $238M | Sell |
1,473,194
-290,068
| -16% | -$44.5M | 0.46% | 38 |
|
|
2022
Q3 | $237M | Sell |
1,763,262
-2,263,387
| -56% | -$325M | 0.48% | 39 |
|
|
2022
Q2 | $617M | Sell |
4,026,649
-355,676
| -8% | -$54.3M | 0.59% | 26 |
|
|
2022
Q1 | $710M | Buy |
4,382,325
+469,612
| +12% | +$68.2M | 0.53% | 35 |
|
|
2021
Q4 | $530M | Sell |
3,912,713
-461,872
| -11% | -$54.6M | 0.36% | 56 |
|
|
2021
Q3 | $472M | Buy |
4,374,585
+297,776
| +7% | +$34M | 0.37% | 55 |
|
|
2021
Q2 | $459M | Sell |
4,076,809
-207,404
| -5% | -$23.4M | 0.39% | 54 |
|
|
2021
Q1 | $464M | Sell |
4,284,213
-552,348
| -11% | -$59.1M | 0.45% | 42 |
|
|
2020
Q4 | $518M | Buy |
4,836,561
+210,031
| +5% | +$20.2M | 0.51% | 39 |
|
|
2020
Q3 | $405M | Sell |
4,626,530
-119,789
| -3% | -$11.3M | 0.47% | 37 |
|
|
2020
Q2 | $466M | Buy |
4,746,319
+400,239
| +9% | +$35.2M | 0.54% | 24 |
|
|
2020
Q1 | $331M | Sell |
4,346,080
-189,584
| -4% | -$16.1M | 0.44% | 39 |
|
|
2019
Q4 | $402M | Buy |
4,535,664
+463,526
| +11% | +$38.5M | 0.37% | 41 |
|
|
2019
Q3 | $308M | Buy |
4,072,138
+65,229
| +2% | +$4.47M | 0.3% | 54 |
|
|
2019
Q2 | $291M | Sell |
4,006,909
-413,558
| -9% | -$32.5M | 0.27% | 68 |
|
|
2019
Q1 | $356M | Sell |
4,420,467
-573,056
| -11% | -$46.9M | 0.35% | 50 |
|
|
2018
Q4 | $460M | Sell |
4,993,523
-731,999
| -13% | -$64.4M | 0.5% | 29 |
|
|
2018
Q3 | $542M | Sell |
5,725,522
-1,782,388
| -24% | -$169M | 0.49% | 27 |
|
|
2018
Q2 | $696M | Sell |
7,507,910
-406,808
| -5% | -$39.7M | 0.67% | 17 |
|
|
2018
Q1 | $749M | Sell |
7,914,718
-136,400
| -2% | -$15M | 0.71% | 17 |
|
|
2017
Q4 | $779M | Sell |
8,051,118
-187,153
| -2% | -$17.6M | 0.61% | 21 |
|
|
2017
Q3 | $732M | Sell |
8,238,271
-696,140
| -8% | -$53M | 0.63% | 16 |
|
|
2017
Q2 | $648M | Sell |
8,934,411
-529,159
| -6% | -$35.6M | 0.62% | 12 |
|
|
2017
Q1 | $617M | Sell |
9,463,570
-260,511
| -3% | -$16.4M | 0.6% | 13 |
|
|
2016
Q4 | $609M | Sell |
9,724,081
-593,231
| -6% | -$36.2M | 0.54% | 18 |
|
|
2016
Q3 | $650M | Sell |
10,317,312
-500,538
| -5% | -$32.4M | 0.63% | 17 |
|
|
2016
Q2 | $670M | Sell |
10,817,850
-2,180,822
| -17% | -$133M | 0.71% | 17 |
|
|
2016
Q1 | $742M | Buy |
12,998,672
+35,328
| +0.3% | +$1.97M | 0.85% | 14 |
|
|
2015
Q4 | $769M | Buy |
12,963,344
+698,563
| +6% | +$40.2M | 0.87% | 14 |
|
|
2015
Q3 | $667M | Sell |
12,264,781
-573,723
| -4% | -$37.3M | 0.79% | 20 |
|
|
2015
Q2 | $863M | Buy |
12,838,504
+4,363,582
| +51% | +$285M | 0.92% | 8 |
|
|
2015
Q1 | $496M | Buy |
8,474,922
+1,608,768
| +23% | +$97.2M | 0.57% | 31 |
|
|
2014
Q4 | $449M | Buy |
6,866,154
+995,263
| +17% | +$62.7M | 0.5% | 38 |
|
|
2014
Q3 | $339M | Buy |
5,870,891
+348,390
| +6% | +$19.3M | 0.41% | 54 |
|
|
2014
Q2 | $312M | Sell |
5,522,501
-1,105,634
| -17% | -$58M | 0.39% | 61 |
|
|
2014
Q1 | $341M | Sell |
6,628,135
-1,909,369
| -22% | -$96.5M | 0.41% | 54 |
|
|
2013
Q4 | $451M | Sell |
8,537,504
-1,221,542
| -13% | -$60M | 0.57% | 32 |
|
|
2013
Q3 | $437M | Buy |
9,759,046
+1,768,833
| +22% | +$78.4M | 0.58% | 31 |
|
|
2013
Q2 | $330M | Buy |
+7,990,213
| New | +$349M | 0.47% | 51 |
|
Other funds holding ABBV
VCM
VPM
Allianz Asset Management's ABBV Position: Q1 2026 in Review
Allianz Asset Management increased its AbbVie (ABBV) stake by 11% in Q1 2026, buying an estimated $29.9M and bringing the position to 1,393,938 shares worth $303M. The position accounts for 0.32% of the portfolio, ranked #61.
Allianz Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $863M in Q2 2015. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Allianz Asset Management held 1,393,938 shares of AbbVie worth $303M as of Q1 2026.
- Allianz Asset Management bought 134,715 AbbVie shares in Q1 2026, an estimated $29.9M.
- AbbVie made up 0.32% of Allianz Asset Management's portfolio in Q1 2026, its #61 holding.
- Allianz Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's AbbVie position peaked at $863M in Q2 2015.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.